logo

ABUS

Arbutus Biopharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
4.62 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is ABUS a Good Buy Right Now?
  • Based on a composite score of 4.62/10, we rate ABUS as a Netural. Our analysis breaks down into 4.32/10 for Fundamentals, 4.17/10 for Technicals, and 5.00/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is ABUS undervalued or overvalued?
Technical Analysis of ABUS?
Is money flowing into or out of ABUS?